South Korea's home healthcare market was valued at $5.29 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $10.50 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the increased prevalence of chronic ailments. The market is segmented by equipment outlook and by services. Some key players in this market are BAYDA Home Healthcare, Samsung Medical Centre, Seoul National University Hospital, Asan Medical Center, and the National Health Insurance Service (NHIS).
In South Korea, the Ministry of Health and Welfare is the main regulatory body for home healthcare. The Ministry sets policies and regulations for home healthcare services, and it also oversees the implementation of these policies and regulations. The Ministry also provides funding and support for home healthcare services, and it works with other government agencies and private organizations to ensure that home healthcare services are provided to those who need them. Additionally, the National Health Insurance Service (NHIS) also plays a role in overseeing and regulating home healthcare services in South Korea, by ensuring the reimbursement and the quality of the service provided.
Market Growth Drivers
The prevalence of chronic conditions like hypertension, diabetes, arthritis, cancer, and cardiovascular illnesses is on the rise, which is helping the market expand. At least one chronic illness is present in 50% of all patients receiving home healthcare, and this percentage is predicted to rise with time. Long-lasting chronic sickness is a condition that can be managed but not healed. Chronic disease management and treatment has grown to be a top priority. As the population in South Korea ages, the demand for home healthcare services is expected to increase. This is because older adults are more likely to have chronic health conditions that require ongoing care and support. As healthcare costs continue to rise in South Korea, more patients are looking for ways to reduce their healthcare expenses. Home healthcare can be more cost-effective than hospital-based care, which is driving demand for these services. Due to the COVID-19 pandemic, people are more willing to receive care at home to avoid the risk of infection.
Market Restraints
The lack of skilled nursing personnel with a compassionate attitude is anticipated to slow the rate of expansion of the South Korea home healthcare market. There is a shortage of healthcare professionals, particularly nurses, in South Korea, which can make it difficult for home healthcare providers to meet the needs of patients. Home healthcare services can be expensive, and many patients are unable to afford them. This can be a barrier to accessing home healthcare services, particularly for those who are low-income or have limited insurance coverage. South Korea has an aging population, which is leading to an increase in the number of patients requiring home healthcare services. This puts pressure on the home healthcare system to adapt to the needs of older patients.
Key Players
In 2020, Samsung BioLogics announced a partnership with the National Health Insurance Service (NHIS) to develop a telemedicine platform for home healthcare services. The partnership aims to use technology to improve access to healthcare for patients in remote and rural areas.
In 2019, SoftBank invested in a South Korean home healthcare startup called MediBid. The startup offers a platform that connects patients with home healthcare providers, and the investment is expected to help the company expand its services.
In 2018, Samsung C&T Corporation, a subsidiary of Samsung Group, announced that it would invest $1.1 billion in a joint venture with a home healthcare provider, Medwell. The joint venture aims to develop and market home healthcare services and products.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Device Type (Revenue, USD Billion):
Based on the Device Type the market is segmented into Testing, Screening, Monitoring Devices, Therapeutic Home Healthcare Devices, and Mobility Assist.
By Service Type (Revenue, USD Billion):
By Indication Type (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.